Kara M. Soroko

Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in Glioblastoma

J. Bryan Iorgulescu, Prafulla C. Gokhale, Maria C. Speranza et al. · Clinical Cancer Research · 2020 · 157 citations · Full text

An allosteric inhibitor against the therapy-resistant mutant forms of EGFR in non-small cell lung cancer

Ciric To, Tyler S. Beyett, Jaebong Jang et al. · Nature Cancer · 2022 · 146 citations · Full text

Therapy-resistant Mutant Forms, Medicine, Pharmacology +9

Combined Targeting of the BRD4–NUT–p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734

Chevaun D. Morrison-Smith, Tatiana M. Knox, Ivona Filic et al. · Molecular Cancer Therapeutics · 2020 · 83 citations · Full text

ERK Inhibitor LY3214996-Based Treatment Strategies for<i>RAS</i>-Driven Lung Cancer

Jens Köhler, Yutong Zhao, Jiaqi Li et al. · Molecular Cancer Therapeutics · 2021 · 31 citations · Full text

Quinazolinones as allosteric fourth-generation EGFR inhibitors for the treatment of NSCLC

Thomas W. Gero, David E. Heppner, Tyler S. Beyett et al. · Bioorganic & Medicinal Chemistry Letters · 2022 · 21 citations · Full text

Medicinal Chemistry, Medicine, Pharmacotherapy +6